In patients with MM who have the t(4;14) translocation, overexpressed NSD2 causes global augmentation in H3K36me2, alters distribution across the genome, and leads to a concomitant genome-wide reduction of H3K27 methylation (7, 16, 17). This evidence concerns the gene NSD2 and Miyoshi myopathy.